Circulating Tumor DNA Correlates with Outcome in Metastatic Melanoma Treated by BRAF and MEK Inhibitors – Results of a Prospective Biomarker Study.
Andrea Forschner1, Stephanie Weißgraeber2, Dirk Hadaschik2, Martin Schulze3, Maria Kopp2, Sabine Kelkenberg2, Tobias Sinnberg1, Claus Garbe1, Saskia Biskup2,3, […]